TY - JOUR KW - General Medicine KW - Covid-19 KW - Hanseníase KW - Epidemiologia AU - Silva JDALPD AU - Oliveira AEAD AU - Macri PP AU - Oliveira WM AU - Silva TM AU - Dias HB AU - Dantas MCB AU - Santos HTP AU - Damasceno SS AU - Serpa GSDM AU - Júnior GPX AU - Galvão EMLNF AU - Araujo VFSD AU - Maslinkiewicz A AB -
Leprosy is a chronic infectious pathology mainly caused by the intracellular pathogen Mycobacterium leprae. This bacterium especially inhabits skin macrophages and Schwann cells of peripheral nerves, causing skin disease and/or neuritis. COVID-19 is a severe acute respiratory disease (SARS-CoV-2), it emerged recently, while the causative agent of leprosy lasts for more than 2,000 years. Thus, the studies were published in the years 2020, 2021 and 2022, being the equivalent of 14.29% in the year 2020, 71.42% in the year 2021 and about 14.29% in the year 2022, most of the works were from Brazil 85.71%, against 14.29% from Nepal. Regarding the results exposed, it is worth noting that, due to the decrease in the underreporting of endemic diseases, such as leprosy, due to COVID-19 infection, concerns have arisen about the diagnosis and treatment of the disease because of the reduction in notification and demand from users. during the pandemic due to social isolation. Among the main issues, we can highlight the increase in the difficulty of access to health and poverty due to the obstruction of non-essential services, which mainly affects those who already live in precarious conditions.
BT - International Journal of Advanced Engineering Research and Science DO - 10.22161/ijaers.910.4 IS - 10 LA - Por N2 -Leprosy is a chronic infectious pathology mainly caused by the intracellular pathogen Mycobacterium leprae. This bacterium especially inhabits skin macrophages and Schwann cells of peripheral nerves, causing skin disease and/or neuritis. COVID-19 is a severe acute respiratory disease (SARS-CoV-2), it emerged recently, while the causative agent of leprosy lasts for more than 2,000 years. Thus, the studies were published in the years 2020, 2021 and 2022, being the equivalent of 14.29% in the year 2020, 71.42% in the year 2021 and about 14.29% in the year 2022, most of the works were from Brazil 85.71%, against 14.29% from Nepal. Regarding the results exposed, it is worth noting that, due to the decrease in the underreporting of endemic diseases, such as leprosy, due to COVID-19 infection, concerns have arisen about the diagnosis and treatment of the disease because of the reduction in notification and demand from users. during the pandemic due to social isolation. Among the main issues, we can highlight the increase in the difficulty of access to health and poverty due to the obstruction of non-essential services, which mainly affects those who already live in precarious conditions.
PB - AI Publications PY - 2022 SP - 025 EP - 033 T2 - International Journal of Advanced Engineering Research and Science TI - Leprosy in times of the COVID-19 pandemic: An integrative literature review UR - https://ijaers.com/uploads/issue_files/4IJAERS-10202210-Leprosy.pdf VL - 9 SN - 2349-6495, 2456-1908 ER -